The TidalHealth Guerrieri Heart & Vascular Institute supports clinical research and trials offered to cardiovascular patients. Several studies at TidalHealth Peninsula Regional have gone on to become national protocol. For example, the P2Y12 – platelet inhibitors (brilinta and effient) and the bio-reabsorbable stent trial included our patients.
We are proud to work with Clinical Research to bring the latest technologies to patients in our community.
TidalHealth Cardiology participates in Phase II – IV clinical drug and device research. Our mission is to promote patient health and education by providing cutting-edge cardiology research for the Delmarva Peninsula.
Our areas of interest include:
- Coronary Artery Disease
- Heart Attack
- Peripheral Vascular Disease
- Cardiovascular Stents
- Congestive Heart Failure
- Atrial Fibrillation
For more information, visit our TidalHealth Richard A. Henson Research Institute page.